On April 6, 2020, the U.S. Drug Enforcement Agency (“DEA”) made history by descheduling Epidiolex, GW Pharmaceuticals’ anti-epileptic oral solution containing cannabiodiol (“CBD”), thereby removing it from the purview of
Continue Reading DEA Deschedules Cannabinol-Containing Epidiolex
On March 5, 2020, the Commissioner of the U.S. Food and Drug Administration (FDA) released a statement describing the agency’s continued evaluation of cannabidiol (CBD) products and signaling issuance of
Continue Reading FDA Commissioner Signals Enforcement Policy, Advancement of Research for CBD Products
This post originally appeared as an article in Cannabis Business Executive on December 5, 2019.
A cannabis product business is no simple venture. Cannabusinesses have to innovate to remain
Continue Reading Intellectual Property in the Cannabis Industry – Protecting Innovations And Products, Part I (Trade Secrets)
On November 25, 2019, FDA issued Warning Letters to 15 companies illegally marketing cannabidiol (CBD) products. On the same day, U.S. Food & Drug Administration (FDA) published a revised consumer
Continue Reading FDA Issues Warning Letters to 15 Companies, Consumer Update on CBD Safety
As we have long expected, the plaintiff’s bar has focused its attention on the growing CBD product sector. A series of recently filed lawsuits signal that it is more important than ever for participants in the CBD market to know where their product is coming from and to document their testing and labeling methodologies.
Continue Reading CBD Unfair Competition and False Advertising Lawsuits Are On The Rise
Last week, in what may be the first of its kind, a putative class of Massachusetts consumers filed a false labeling class action complaint against Global Widget LLC, d/b/a Hemp Bombs (“Hemp Bombs”) (Ahumada v. Global Widget LLC, D. Mass. Case No. 1:19-cv-12005), challenging the labeling of numerous Hemp Bombs products, including gummies, lollipops, capsules, syrup, vape and pet products.
Continue Reading CBD Industry Beware: The False Labeling Class Action Has Arrived
While the legal landscape continues to evolve in the cannabis industry, making entry into the space a potentially risky proposition, the passage of the Agriculture Improvement Act of 2018 (the “Farm Bill”) can be a real game changer in attracting mainstream companies to the industry.
Continue Reading The Farm Bill’s Impact on Hemp and CBD – and How Some States are Reacting